The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.

Medicina (Kaunas) · 2022 · PMC8779899 · PMID 35056396

Europe PMC DOI

hedged sentence

0.0090

closest p · 0.2× alpha

0.0090

boldest claim

The sentences

highly significantp < 0.009actually significant

This is in contrast with the highly significant correlation between ADOSE and ATSUI (r = 0.497; p < 0.009).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.